Theriva Biologics, Inc. Accumulated Other Comprehensive Income
Theriva Biologics, Inc. (TOVX) had Accumulated Other Comprehensive Income of $247.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-11
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $247.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $377.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $755.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $763.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax | Accumulated Other Comprehensive Income (Loss), Net of Tax as first filed |
|---|---|---|
| 2026-06-30 | $247.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $377.00K 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $755.00K 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $763.00K 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $793.00K 10-Q · filed 2025-08-11 | |
| 2025-03-31 | -$524.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$1.18M 10-K · filed 2026-03-12 | |
| 2024-09-30 | $112.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$709.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$537.00K 10-Q · filed 2024-05-07 | |
| 2023-12-31 | $32.00K 10-K · filed 2025-03-06 | |
| 2023-09-30 | -$1.06M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$356.00K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | -$305.00K 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$679.00K 10-K · filed 2024-03-25 | |
| 2022-09-30 | -$2.73M 10-K · filed 2023-03-30 | -$2.84M 10-Q · filed 2022-11-10 |
| 2022-06-30 | -$1.26M 10-K · filed 2023-03-30 | -$1.32M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $181.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |